Get started
Author

Кролевец Татьяна Сергеевна

Observed names: T S Krolevets, T. S. Krolevets, T.S. Krolevets, T.S. Krolevets Krolevets, Tatyana Krolevets, Tatyana S. Krolevets, Кролевец Т.С., Т. С. Кролевец
ORCID: 0000-0002-7452-7230
Observed ORCID: 0000-0002-7452-7230
OpenAlex ID: A5039684772
Non-alcoholic fatty liver disease: digest 2021
2021 · T.S. Krolevets, V.A. Livzan · Russian Journal of Evidence-Based Gastroenterology · 14
Non-alcoholic fatty liver disease and women's health
2023 · M.A. Livzan, M.I. Syrovenko, et al. · Russian Medical Inquiry · 13
PDF
Cardiovascular Diseases and Non-Alcoholic Fatty Liver Disease: Relationship and Pathogenetic Aspects of Pharmacotherapy
2022 · A. V. Nelidova, M. A. Livzan, et al. · Rational Pharmacotherapy in Cardiology · 12
PDF
The informative value of non-invasive liver fibrosis markers in patients with nonalcoholic fatty liver disease
2016 · M A Livzan, V A Akhmedov, et al. · Terapevticheskii arkhiv · 11
PDF
Neuroendocrine Tumour as a Diagnostic and Prognostic Criterion for Autoimmune Gastritis
2020 · S. I. Mozgovoi, M. A. Livzan, et al. · Russian Journal of Gastroenterology Hepatology Coloproctology · 8
PDF
Specific features of gastroesophageal reflux disease associated with obesity and overweight
2016 · M. A. Livzan, I. V. Lapteva, et al. · Terapevticheskii arkhiv · 8
Liver fibrosis in nonalcoholic fatty liver disease: the role of adipokines and noninvasive assessment of the intestinal barrier
2023 · T.S. Krolevets, M.A. Livzan, et al. · Russian Journal of Evidence-Based Gastroenterology · 7
Adherence to lifestyle modification in patients with nonalcoholic fatty liver disease
2022 · K. A. Andreev, Yu. P. Skirdenko, et al. · Bulletin of Siberian Medicine · 6
PDF
Features of the course of gallstone disease in patients with non-alcoholic fatty liver disease
2020 · N. A. Cherkashchenko, M. A. Livzan, et al. · Terapevticheskii arkhiv · 6
PDF
Autoimmune gastritis: from symptom to diagnosis. Clinical observations
2020 · Maria A. Livzan, Tatyana S. Krolevets, et al. · Consilium Medicum · 6
Autoimmune gastritis in the focus of clinician and morphologist
2019 · S.I. Mozgovoy Mozgovoy, M.B. Kostenko Kostenko, et al. · Фарматека · 6
Cardiovascular comorbidity in non-alcoholic fatty liver disease
2020 · A. Yu. Timakova, Yu. P. Skirdenko, et al. · Экспериментальная и клиническая гастроэнтерология · 5
PDF
Autoimmune gastritis and stomach cancer: assessing the risks
2023 · A. V. Gubanova, M. A. Livzan, et al. · Экспериментальная и клиническая гастроэнтерология · 4
PDF
Pathogenic aspects of the comorbid course of non-alcoholic fatty liver disease and cholelithiasis: a review and the authors’ results
2022 · T.S. Krolevets, M.A. Livzan, et al. · Russian Medical Inquiry · 4
PDF
Are physicians ready to comply with the guidelines for diagnosis and management of Helicobacter pylori-associated diseases: the survey results 2020–2021
2021 · D. S. Bordin, T. S. Krolevets, et al. · Almanac of Clinical Medicine · 4
PDF
Decision support system for predicting metabolic risks in patients with comorbid non-alcoholic fatty liver disease and gallstone disease after cholecystectomy
2020 · N. A. Cherkashchenko, M. A. Livzan, et al. · Medical alphabet · 4
PDF
Consent of Doctors to Guidelines for the Diagnosis and Treatment of Diseases Associated with Helicobacter pylori
2019 · D.S. Bordin, T.S. Krolevets, et al. · Effective Pharmacotherapy · 4
PDF
The many faces of the problem of intolerance to gluten.
2018 · M. A. Livsan, M. F. Osipenko, et al. · Clinical Medicine (Russian Journal) · 4
Early disease detection expert system development: primary machining software applications and dependences
2018 · A. S. Serobabov, E. V. Chebanenko, et al. · Omsk Scientific Bulletin · 4
PDF
Matrix Metalloproteinases and Their Tissue Inhibitors in Patients with Nonalcoholic Fatty Liver Disease
2016 · Tatyana Krolevets, Maria Livzan, et al. · Journal of Pharmacy and Pharmacology · 4
PDF
Leptin resistance in patients with nonalcoholic fatty liver disease associated with obesity and overweight
2015 · M. A. Livzan, I. V. Lapteva, et al. · DOAJ (DOAJ: Directory of Open Access Journals) · 4
Lifestyle of patients with non-alcoholic fatty liver disease: assessment of dietary habits and physical activity
2023 · T.S. Krolevets, M.I. Syrovenko, et al. · Russian Journal of Evidence-Based Gastroenterology · 3
A New Look at the Pathogenesis and Possibilities of Treatment and Prevention of Autoimmune Diseases with the Role of the Intestinal Barrier and Increased Intestinal Permeability
2021 · T.V. Kostoglod, T.S. Krolevets, et al. · Effective Pharmacotherapy · 3
PDF
Clinical features of the comorbid course of non-alcoholic fatty liver disease and gallstone disease
2020 · N. A. Cherkashchenko, M. A. Livzan, et al. · Terapevticheskii arkhiv · 3
PDF
[assessment of Matrix Metalloproteinases and Their Tissue Inhibitors for Non-invasive Diagnosis of Liver Fibrosis in Patients With Nonalcoholic Fatty Liver Disease].
2016 · M A Livzan, I V Lapteva, et al. · PubMed · 3
Works count: 65
Citation count: 170
H-index: 7
I10-index: 4
Year
Topic
Type